Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
E03T0010Mouse anti-Tissue type Plasminogen Activator ELISA KitBlueGen96 Tests/kit1087.8 E03T0010 Mouse anti-Tissue type Plasminogen Activator ELISA Kit BlueGen 96 Tests/kit 1087.8
ASK
Publication
IHTPA-0.1mgHuman tissue plasminogen activator, 85% single chain 0.1mgInnovative Research INC0.1mg504 IHTPA-0.1mg Human tissue plasminogen activator, 85% single chain 0.1mg Innovative Research INC 0.1mg 504
ASK
Publication
IHTPA-1mgHuman tissue plasminogen activator, 85% single chain 1mgInnovative Research INC1mg1619 IHTPA-1mg Human tissue plasminogen activator, 85% single chain 1mg Innovative Research INC 1mg 1619 Publication
MD-14-0576Rabbit Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech200 411 MD-14-0576 Rabbit Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 411 Publication
MD-14-0575Mouse Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech200 411 MD-14-0575 Mouse Anti-Human Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 411 Publication
MD-14-1161Rabbit Anti-Mouse Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech200 328 MD-14-1161 Rabbit Anti-Mouse Tissue Plasminogen Activator (tPA) PLAT Antibodies Ray Biotech 200 328
ASK
Publication
mAP-0143Rat monoclonal anti mouse Urokinase-type Plasminogen Activator Receptor (uPAR) Anti-Mouse antibodiesAngoiPro100.00 ug310 mAP-0143 Rat monoclonal anti mouse Urokinase-type Plasminogen Activator Receptor (uPAR) Anti-Mouse antibodies AngoiPro 100.00 ug 310 Publication
IC03001Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805US Biomax231 IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805 US Biomax 231
ASK
Publication
T033Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 coresUS Biomax88 T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
LV2091Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmedUS Biomax429 LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
T031Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 coresUS Biomax88 T031 Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores US Biomax 88
ASK
Publication
CSB-EL010048HUHuman guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasmaCusabio96T913 CSB-EL010048HU Human guanylate cyclase activator 2B (uroguanylin) (GUCA2B) ELISA kit, Species Human, Sample Type serum, plasma Cusabio 96T 913 Publication
LV806Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 coresUS Biomax231 LV806 Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases 80 cores US Biomax 231
ASK
Publication
LV804Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011US Biomax231 LV804 Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011 US Biomax 231
ASK
Publication
LV241Liver cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 coresUS Biomax88 LV241 Liver cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88
ASK
Publication
LV801Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases 80 coresUS Biomax231 LV801 Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases 80 cores US Biomax 231
ASK
Publication
LV20812Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 coresUS Biomax456 LV20812 Liver tissue cancer tissue array, containing HBV infection, TNM and pathology grade information, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2161Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 coresUS Biomax456 LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases 216 cores US Biomax 456
ASK
Publication
LV2089Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
LV483Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 coresUS Biomax160 LV483 Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases 48 cores US Biomax 160
ASK
Publication
LV242Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 LV242 Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
LV802Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801US Biomax189 LV802 Liver carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with LV801 US Biomax 189
ASK
Publication
BC03013Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723US Biomax160 BC03013 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723 US Biomax 160
ASK
Publication
LV20811Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BC03011Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010US Biomax160 BC03011 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010 US Biomax 160
ASK
Publication
LV20810Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
LV486Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 coresUS Biomax231 LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231
ASK
Publication
LV245Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
BC03011Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmedUS Biomax185 BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed US Biomax 185
ASK
Publication
T032Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 coresUS Biomax88 T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
LV208Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade infoUS Biomax456 LV208 Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info US Biomax 456
ASK
Publication
mAP-0089Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-2) Anti-Mouse antibodiesAngoiPro100.00 ug310 mAP-0089 Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-2) Anti-Mouse antibodies AngoiPro 100.00 ug 310 Publication
mAP-0088Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-1) Anti-Mouse antibodiesAngoiPro100.00 ug310 mAP-0088 Rat monoclonal anti mouse HGF Activator Inhibitor type 1 (HAI-1) Anti-Mouse antibodies AngoiPro 100.00 ug 310 Publication
LV487Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmedUS Biomax185 LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
RD182028100Mouse Monoclonal Antibody, Clone: 6G3; Arginase Liver Type , Anti-HumanBiovendor0.1 mg258 RD182028100 Mouse Monoclonal Antibody, Clone: 6G3; Arginase Liver Type , Anti-Human Biovendor 0.1 mg 258 Publication
LVC1021Liver cancer tissue array, 102 cases 102 coresUS Biomax225 LVC1021 Liver cancer tissue array, 102 cases 102 cores US Biomax 225
ASK
Publication
TR031Rat normal liver test tissue array, 6 cases 24 coresUS Biomax88 TR031 Rat normal liver test tissue array, 6 cases 24 cores US Biomax 88
ASK
Publication
LF-MA0190anti-Plasminogen (44A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host MouseAbfrontier100 ul355 LF-MA0190 anti-Plasminogen (44A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
LC501Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 coresUS Biomax160 LC501 Tissue array of multi type lung cancer and normal tissue with TNM and grade, 50 cases 50 cores US Biomax 160
ASK
Publication
BC01071Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 coresUS Biomax160 BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases 48 cores US Biomax 160
ASK
Publication
LV807Liver cancer and normal tissue array with TNM and grade, 40 cases 80 coresUS Biomax231 LV807 Liver cancer and normal tissue array with TNM and grade, 40 cases 80 cores US Biomax 231
ASK
Publication
FMS152Liver of multiple species frozen tissue array, 14 cases 15 coresUS Biomax293 FMS152 Liver of multiple species frozen tissue array, 14 cases 15 cores US Biomax 293
ASK
Publication
MO03011Mouse liver tissue array, 100 cases 100 cores, 50 male and 50 femaleUS Biomax160 MO03011 Mouse liver tissue array, 100 cases 100 cores, 50 male and 50 female US Biomax 160
ASK
Publication
LF-MA0189anti-Plasminogen (9A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host MouseAbfrontier100 ul355 LF-MA0189 anti-Plasminogen (9A1), Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
LF-MA0170anti-Plasminogen, Mouse monoclonal to Plasminogen, Isotype IgG1, Host MouseAbfrontier100 ul355 LF-MA0170 anti-Plasminogen, Mouse monoclonal to Plasminogen, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
LVC962Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 coresUS Biomax189 LVC962 Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 cores US Biomax 189
ASK
Publication
LVC481Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 coresUS Biomax166 LVC481 Liver cancer and normal tissue array, non overlapping with LVC482, 16 cases 48 cores US Biomax 166
ASK
Publication
LV805Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001US Biomax231 LV805 Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001 US Biomax 231
ASK
Publication
LV244Liver cancer tissue array, with stage and grade info, 8 cases 24 coresUS Biomax88 LV244 Liver cancer tissue array, with stage and grade info, 8 cases 24 cores US Biomax 88
ASK
Publication
BN03011Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801US Biomax160 BN03011 Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801 US Biomax 160
ASK
Publication
LV1501Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 coresUS Biomax321 LV1501 Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321
ASK
Publication
LV2081Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 coresUS Biomax516 LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516
ASK
Publication
LVC1502Liver cancer mid density tissue array, non overlapping with LVC1501 or LVC1503, 75 cases 150 coresUS Biomax225 LVC1502 Liver cancer mid density tissue array, non overlapping with LVC1501 or LVC1503, 75 cases 150 cores US Biomax 225
ASK
Publication
LV808Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 coresUS Biomax231 LV808 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231
ASK
Publication
LVC1501Liver cancer mid density tissue array, non overlapping with LVC1502 or LVC1503, 75 cases 150 coresUS Biomax225 LVC1501 Liver cancer mid density tissue array, non overlapping with LVC1502 or LVC1503, 75 cases 150 cores US Biomax 225
ASK
Publication
LV2082Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 coresUS Biomax456 LV2082 Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases 208 cores US Biomax 456
ASK
Publication
LV2001High density liver cancer tissue array, paraffin section, 200 cases 200 coresUS Biomax397 LV2001 High density liver cancer tissue array, paraffin section, 200 cases 200 cores US Biomax 397
ASK
Publication
LV8011Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 coresUS Biomax231 LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231
ASK
Publication
LVC2281Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161US Biomax403 LVC2281 Liver cancer high density tissue array, 228 cases 228 cores, replaced by LV2161 US Biomax 403
ASK
Publication
LV484Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 coresUS Biomax231 LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores US Biomax 231
ASK
Publication
LV243Liver cancer tissue array with normal tissues from autopsy, 12 cases 24 cores, with grade and stageUS Biomax88 LV243 Liver cancer tissue array with normal tissues from autopsy, 12 cases 24 cores, with grade and stage US Biomax 88
ASK
Publication
LVC961Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 coresUS Biomax189 LVC961 Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC962, 48 cases 96 cores US Biomax 189
ASK
Publication
LV482Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases 48 coresUS Biomax160 LV482 Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases 48 cores US Biomax 160
ASK
Publication
LV1003Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 coresUS Biomax314 LV1003 Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases 100 cores US Biomax 314
ASK
Publication
BC03021Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803US Biomax231 BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803 US Biomax 231
ASK
Publication
LVC482Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 coresUS Biomax166 LVC482 Liver cancer and normal tissue array, with TNM and grade info, non overlapping with LVC481, 16 cases 48 cores US Biomax 166
ASK
Publication
LV1002Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 coresUS Biomax231 LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231
ASK
Publication
LV8012Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 coresUS Biomax231 LV8012 Mid advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231
ASK
Publication
LV2084Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax516 LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 516
ASK
Publication
BC03118Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 coresUS Biomax456 BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456
ASK
Publication
BC03002Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 coresUS Biomax266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
LV2088Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV1201Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax397 LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 397
ASK
Publication
BC03116Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 coresUS Biomax231 BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
LV8010Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011US Biomax231 LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 US Biomax 231
ASK
Publication
LV2087Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
LV481Liver cancer tissue array with normal adjacent tissues, 23 cases 48 cores, with grade and stage dataUS Biomax160 LV481 Liver cancer tissue array with normal adjacent tissues, 23 cases 48 cores, with grade and stage data US Biomax 160
ASK
Publication
LV2086Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
5121ZONZearalenone Mycotoxins ELISA Incubation time (minutes) 90; Tissue Muscle (ppb)6; Feed (ppb); Urine (ppb)2; 2 liverEuroProxima96 wells0 5121ZON Zearalenone Mycotoxins ELISA Incubation time (minutes) 90; Tissue Muscle (ppb)6; Feed (ppb); Urine (ppb)2; 2 liver EuroProxima 96 wells 0
ASK
Publication
LV2085Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 coresUS Biomax456 LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC03119Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 coresUS Biomax278 BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278
ASK
Publication
LV2083High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 coresUS Biomax456 LV2083 High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456
ASK
Publication
LV723Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013US Biomax231 LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231
ASK
Publication
LV485Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 coresUS Biomax397 LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases 96 cores US Biomax 397
ASK
Publication
LV6161High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 coresUS Biomax753 LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753
ASK
Publication
BM01011Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601US Biomax278 BM01011 Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601 US Biomax 278
ASK
Publication
LV962Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV1502Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmedUS Biomax258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LVN801Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011US Biomax231 LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231
ASK
Publication
LV8010Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmedUS Biomax296 LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
MO1601Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011US Biomax278 MO1601 Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011 US Biomax 278
ASK
Publication
CO2085aHigh density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) tissue array with normal colon from autopsy and cancer adjacent tissueUS Biomax456 CO2085a High density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue US Biomax 456
ASK
Publication
T032aLiver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmedUS Biomax90 T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LV803Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021US Biomax231 LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 US Biomax 231
ASK
Publication
LV1921Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 coresUS Biomax456 LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
BC05115Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702US Biomax231 BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231
ASK
Publication
GI961GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 coresUS Biomax231 GI961 GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores US Biomax 231
ASK
Publication
T034Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmedUS Biomax90 T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
ST803Stomach adenocarcinoma tissue array, in various type, 40 cases 80 coresUS Biomax231 ST803 Stomach adenocarcinoma tissue array, in various type, 40 cases 80 cores US Biomax 231
ASK
Publication
BN242Multiple normal (12 type) tissue array, 12 cases 24 coresUS Biomax88 BN242 Multiple normal (12 type) tissue array, 12 cases 24 cores US Biomax 88
ASK
Publication
ST804Stomach adenocarcinoma tissue array, mucous type, 40 cases 80 coresUS Biomax231 ST804 Stomach adenocarcinoma tissue array, mucous type, 40 cases 80 cores US Biomax 231
ASK
Publication
MC242Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245US Biomax88 MC242 Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245 US Biomax 88
ASK
Publication
BN243Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241US Biomax88 BN243 Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 US Biomax 88
ASK
Publication
MC241Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244US Biomax88 MC241 Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244 US Biomax 88
ASK
Publication
BN481Multiple human normal organ (12 type) tissue microarray, 24 cases 48 coresUS Biomax160 BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases 48 cores US Biomax 160
ASK
Publication
MC482Multiple cancer (12 type) tissue microarray, 40 cases 48 cores, with stage and grade informationUS Biomax160 MC482 Multiple cancer (12 type) tissue microarray, 40 cases 48 cores, with stage and grade information US Biomax 160
ASK
Publication
BC07015Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012US Biomax231 BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231
ASK
Publication
00178-VHIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence.Virogen100 µg280 00178-V HIV type O envelope antigen. Synthetic HIV type O peptide, containing the HIV type O envelope derived sequence. Virogen 100 µg 280
ASK
Publication
MC245Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242US Biomax88 MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88
ASK
Publication
IRPLG-1mgRat Plasminogen 1mgInnovative Research INC1mg816 IRPLG-1mg Rat Plasminogen 1mg Innovative Research INC 1mg 816 Publication
IMPLG-1mgMouse Plasminogen 1mgInnovative Research INC1mg374 IMPLG-1mg Mouse Plasminogen 1mg Innovative Research INC 1mg 374 Publication
IDPLG-1mgCanine Plasminogen 1mgInnovative Research INC1mg949 IDPLG-1mg Canine Plasminogen 1mg Innovative Research INC 1mg 949 Publication
IHGPG-1mgHuman Glu Plasminogen 1mgInnovative Research INC1mg421 IHGPG-1mg Human Glu Plasminogen 1mg Innovative Research INC 1mg 421 Publication
IRbPLG-1mgRabbit Plasminogen 1mgInnovative Research INC1mg878 IRbPLG-1mg Rabbit Plasminogen 1mg Innovative Research INC 1mg 878 Publication
IBPLG-1mgBovine Plasminogen 1mgInnovative Research INC1mg478 IBPLG-1mg Bovine Plasminogen 1mg Innovative Research INC 1mg 478 Publication
ICKPG-1mgChicken Plasminogen 1mgInnovative Research INC1mg535 ICKPG-1mg Chicken Plasminogen 1mg Innovative Research INC 1mg 535 Publication
CO2085bTMA BLOCK of high density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) with normal colon from autopsy and cancer adjacent tissueUS Biomax40981 CO2085b TMA BLOCK of high density (208 cases 208 cores), multiple type colon adenocarcinoma (I 4 grade) with normal colon from autopsy and cancer adjacent tissue US Biomax 40981
ASK
Publication
IRTPLGKTRat Plasminogen ELISA KitInnovative Research INC1 kit(96 Wells)619 IRTPLGKT Rat Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 Publication
IRKTAH1167Pig Plasminogen ELISA KitInnovative Research INC1 kit(96 Wells)597 IRKTAH1167 Pig Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 597 Publication
IDGPLGKTDog Plasminogen ELISA KitInnovative Research INC1 kit(96 Wells)619 IDGPLGKT Dog Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 Publication
IHGPG-10mgHuman Glu Plasminogen 10mgInnovative Research INC1162 IHGPG-10mg Human Glu Plasminogen 10mg Innovative Research INC 1162 Publication
IBPLG-10mgBovine Plasminogen 10mgInnovative Research INC1805 IBPLG-10mg Bovine Plasminogen 10mg Innovative Research INC 1805 Publication
MD-14-0929Rat Anti-Mouse Plasminogen PLG Antibodies Ray Biotech100 386 MD-14-0929 Rat Anti-Mouse Plasminogen PLG Antibodies Ray Biotech 100 386
ASK
Publication
DS-MB-03405Mouse Anti-Human PlasminogenRay Biotech200 566 DS-MB-03405 Mouse Anti-Human Plasminogen Ray Biotech 200 566
ASK
Publication
IRBPLGKTRabbit Plasminogen ELISA KitInnovative Research INC1 kit(96 Wells)619 IRBPLGKT Rabbit Plasminogen ELISA Kit Innovative Research INC 1 kit(96 Wells) 619 Publication
MD-14-0071PNative Human Plasminogen Proteins Ray Biotech1 mg205 MD-14-0071P Native Human Plasminogen Proteins Ray Biotech 1 mg 205 Publication
IHGPGPlasma Proteins: Human Glu PlasminogenInnovative Research INC1mg284 IHGPG Plasma Proteins: Human Glu Plasminogen Innovative Research INC 1mg 284 Publication
IASMPLG-1mlRabbit Anti Mouse Plasminogen Antiserum 1mlInnovative Research INC1ml880 IASMPLG-1ml Rabbit Anti Mouse Plasminogen Antiserum 1ml Innovative Research INC 1ml 880 Publication
DS-PB-02729Rabbit Anti-Human Plasminogen Antibodies Ray Biotech1 ml370 DS-PB-02729 Rabbit Anti-Human Plasminogen Antibodies Ray Biotech 1 ml 370
ASK
Publication
IMPLA-SER-PG-50mlPlasminogen Depleted Mouse Serum 50mlInnovative Research INC1220 IMPLA-SER-PG-50ml Plasminogen Depleted Mouse Serum 50ml Innovative Research INC 1220 Publication
IASMPLG-GF-1mgRabbit Anti Mouse Plasminogen IgG Fraction 1mgInnovative Research INC1mg880 IASMPLG-GF-1mg Rabbit Anti Mouse Plasminogen IgG Fraction 1mg Innovative Research INC 1mg 880 Publication
DS-PB-03022Sheep Anti-Human Plasminogen [+HRP] Antibodies Ray Biotech1 ml411 DS-PB-03022 Sheep Anti-Human Plasminogen [+HRP] Antibodies Ray Biotech 1 ml 411
ASK
Publication
IFIB-25mgHuman Fibrinogen, Plasminogen Depleted 25mgInnovative Research INC126 IFIB-25mg Human Fibrinogen, Plasminogen Depleted 25mg Innovative Research INC 126 Publication
DS-PB-01625Sheep Anti-Human Plasminogen Antibodies Ray Biotech1 ml353 DS-PB-01625 Sheep Anti-Human Plasminogen Antibodies Ray Biotech 1 ml 353
ASK
Publication
T241Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 coresUS Biomax88 T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
DS-PB-03021Sheep Anti-Human Plasminogen [+FITC] Antibodies Ray Biotech1 ml353 DS-PB-03021 Sheep Anti-Human Plasminogen [+FITC] Antibodies Ray Biotech 1 ml 353
ASK
Publication
IMPLGKT-TOTMouse Plasminogen Total Antigen AssayInnovative Research INC1 kit(96 Wells)453 IMPLGKT-TOT Mouse Plasminogen Total Antigen Assay Innovative Research INC 1 kit(96 Wells) 453 Publication
IPLG4G6B11 Antibodies, Mouse: Anti Human Plasminogen, Clone 4G6-B11Innovative Research INC1.0mg752 IPLG4G6B11 Antibodies, Mouse: Anti Human Plasminogen, Clone 4G6-B11 Innovative Research INC 1.0mg 752 Publication
IASMPLG-GF-HRP-1mgRabbit anti mouse plasminogen IgG fraction, HRP labeled 1mgInnovative Research INC1mg1002 IASMPLG-GF-HRP-1mg Rabbit anti mouse plasminogen IgG fraction, HRP labeled 1mg Innovative Research INC 1mg 1002 Publication
IPLG2F6C6 Antibodies, Mouse: Anti Human Plasminogen, Clone 2F6-C6Innovative Research INC1.0mg752 IPLG2F6C6 Antibodies, Mouse: Anti Human Plasminogen, Clone 2F6-C6 Innovative Research INC 1.0mg 752 Publication
IHPLGKT-TOTHuman Plasminogen Total Antigen AssayInnovative Research INC1 kit(96 Wells)326 IHPLGKT-TOT Human Plasminogen Total Antigen Assay Innovative Research INC 1 kit(96 Wells) 326 Publication
DS-PB-01627Sheep Anti-Human Plasminogen (Kringles 1-3) Antibodies Ray Biotech0.2 ml411 DS-PB-01627 Sheep Anti-Human Plasminogen (Kringles 1-3) Antibodies Ray Biotech 0.2 ml 411
ASK
Publication
IPLG9F9C4 Antibodies, Mouse: Anti Human Plasminogen, Clone 9F9-C4Innovative Research INC1.0mg752 IPLG9F9C4 Antibodies, Mouse: Anti Human Plasminogen, Clone 9F9-C4 Innovative Research INC 1.0mg 752 Publication
IFIBPlasma Proteins: Human Fibrinogen, Plasminogen DepletedInnovative Research INC1 Gram302 IFIB Plasma Proteins: Human Fibrinogen, Plasminogen Depleted Innovative Research INC 1 Gram 302 Publication
IASMPLG-GF-BIO-1mgRabbit Anti Mouse Plasminogen IgG Fraction, Biotin Labeled 1mgInnovative Research INC1mg1002 IASMPLG-GF-BIO-1mg Rabbit Anti Mouse Plasminogen IgG Fraction, Biotin Labeled 1mg Innovative Research INC 1mg 1002 Publication
IPLG1C10F2 Antibodies, Mouse: Anti Human Plasminogen, Clone 1C10-F2Innovative Research INC1.0mg752 IPLG1C10F2 Antibodies, Mouse: Anti Human Plasminogen, Clone 1C10-F2 Innovative Research INC 1.0mg 752 Publication
IPLG13C3B10 Antibodies, Mouse: Anti Human Plasminogen, Clone 13C3-B10Innovative Research INC1.0mg752 IPLG13C3B10 Antibodies, Mouse: Anti Human Plasminogen, Clone 13C3-B10 Innovative Research INC 1.0mg 752 Publication
IASMPLG-FITC-1mgRabbit Anti Mouse Plasminogen IgG Fraction, Fluorescein Labeled 1mgInnovative Research INC1mg1002 IASMPLG-FITC-1mg Rabbit Anti Mouse Plasminogen IgG Fraction, Fluorescein Labeled 1mg Innovative Research INC 1mg 1002
ASK
Publication
IPLG11B5B2Plasma Proteins: Anti Human Plasminogen, Clone 11B5-B2Innovative Research INC1.0mg752 IPLG11B5B2 Plasma Proteins: Anti Human Plasminogen, Clone 11B5-B2 Innovative Research INC 1.0mg 752 Publication
A-1231ABT-199 Mechanisms: Bcl-2 inhibitorActivBio5mg194 A-1231 ABT-199 Mechanisms: Bcl-2 inhibitor ActivBio 5mg 194
ASK
Publication
A-1046TAE-684 Mechanisms: ALK inhibitorActivBio5mg217 A-1046 TAE-684 Mechanisms: ALK inhibitor ActivBio 5mg 217
ASK
Publication
A-1911NVP-AEW-541 Mechanisms: IGF-1R inhibitorActivBio5mg404 A-1911 NVP-AEW-541 Mechanisms: IGF-1R inhibitor ActivBio 5mg 404
ASK
Publication
A-1242AMG-208 Mechanisms: c-MET inhbitorActivBio5mg311 A-1242 AMG-208 Mechanisms: c-MET inhbitor ActivBio 5mg 311 Publication
A-1189LDK-378 Mechanisms: ALK inhibitorActivBio5mg1094 A-1189 LDK-378 Mechanisms: ALK inhibitor ActivBio 5mg 1094 Publication
IASMPLG-GF-HT-0.1mgRabbit Anti Mouse Plasminogen Affinity Purified High Titer IgG Fraction 0.1mgInnovative Research INC0.1mg1002 IASMPLG-GF-HT-0.1mg Rabbit Anti Mouse Plasminogen Affinity Purified High Titer IgG Fraction 0.1mg Innovative Research INC 0.1mg 1002
ASK
Publication
A-1013BMS-754807 Mechanisms: IGF-1R inhibitorActivBio5mg240 A-1013 BMS-754807 Mechanisms: IGF-1R inhibitor ActivBio 5mg 240 Publication
A-1105AEE-788 Mechanisms: Multiple RTK inhibitorActivBio5mg276 A-1105 AEE-788 Mechanisms: Multiple RTK inhibitor ActivBio 5mg 276 Publication
A-1139MLN-4924 Mechanisms: NAE inhibitorActivBio5mg252 A-1139 MLN-4924 Mechanisms: NAE inhibitor ActivBio 5mg 252 Publication
A-1155BMS-777607 Mechanisms: c-MET inhbitorActivBio5mg264 A-1155 BMS-777607 Mechanisms: c-MET inhbitor ActivBio 5mg 264
ASK
Publication
A-1089XL-184 (Cabozantinib) Mechanisms: c-MET inhbitorActivBio5mg194 A-1089 XL-184 (Cabozantinib) Mechanisms: c-MET inhbitor ActivBio 5mg 194 Publication
A-1129TKI-258 Mechanisms: FGFR inhibitorActivBio5mg240 A-1129 TKI-258 Mechanisms: FGFR inhibitor ActivBio 5mg 240 Publication
A-1172TAK-441 Mechanisms: Hedgehog inhibitorActivBio5mg545 A-1172 TAK-441 Mechanisms: Hedgehog inhibitor ActivBio 5mg 545
ASK
Publication
A-1058OSI-906 Mechanisms: IGF-1R inhibitorActivBio10mg205 A-1058 OSI-906 Mechanisms: IGF-1R inhibitor ActivBio 10mg 205 Publication
A-1245AZD-8330 Mechanisms: MEK inhibitorActivBio5mg287 A-1245 AZD-8330 Mechanisms: MEK inhibitor ActivBio 5mg 287
ASK
Publication
A-1111NVP-AUY-922 Mechanisms: Hsp90 inhibitorActivBio5mg194 A-1111 NVP-AUY-922 Mechanisms: Hsp90 inhibitor ActivBio 5mg 194
ASK
Publication
A-1147LCL-161 Mechanisms: SMAC mimeticActivBio5mg428 A-1147 LCL-161 Mechanisms: SMAC mimetic ActivBio 5mg 428 Publication
A-1087EMD-1214063 Mechanisms: c-MET inhbitorActivBio5mg287 A-1087 EMD-1214063 Mechanisms: c-MET inhbitor ActivBio 5mg 287
ASK
Publication
A-1182LY-2801653 Mechanisms: c-MET inhbitorActivBio5mg311 A-1182 LY-2801653 Mechanisms: c-MET inhbitor ActivBio 5mg 311
ASK
Publication
A-1065OSI-027 Mechanisms: mTORC1 C2 inhibitorActivBio5mg194 A-1065 OSI-027 Mechanisms: mTORC1 C2 inhibitor ActivBio 5mg 194
ASK
Publication
A-1109ARQ-197 Mechanisms: c-MET inhbitorActivBio10mg194 A-1109 ARQ-197 Mechanisms: c-MET inhbitor ActivBio 10mg 194 Publication
A-1144NVP-HSP-990 Mechanisms: Hsp90 inhibitorActivBio5mg287 A-1144 NVP-HSP-990 Mechanisms: Hsp90 inhibitor ActivBio 5mg 287
ASK
Publication
A-1192MLN-2480 Mechanisms: Raf inhibitorActivBio5mg311 A-1192 MLN-2480 Mechanisms: Raf inhibitor ActivBio 5mg 311
ASK
Publication
A-1085RO-5126766 Mechanisms: Raf and MEK inhibitorActivBio5mg428 A-1085 RO-5126766 Mechanisms: Raf and MEK inhibitor ActivBio 5mg 428
ASK
Publication
A-1056PX-866 Mechanisms: PI3K inhibitorActivBio5mg404 A-1056 PX-866 Mechanisms: PI3K inhibitor ActivBio 5mg 404
ASK
Publication
A-1180GDC-0973 (XL-518) Mechanisms: MEK inhibitorActivBio5mg334 A-1180 GDC-0973 (XL-518) Mechanisms: MEK inhibitor ActivBio 5mg 334 Publication
A-1239LY-2090314 Mechanisms: GSK-3b inhibitorActivBio5mg311 A-1239 LY-2090314 Mechanisms: GSK-3b inhibitor ActivBio 5mg 311
ASK
Publication
A-1108BKM-120 Mechanisms: PI3K inhibitorActivBio5mg194 A-1108 BKM-120 Mechanisms: PI3K inhibitor ActivBio 5mg 194 Publication
A-1143BGJ-398 Mechanisms: FGFR inhibitorActivBio5mg194 A-1143 BGJ-398 Mechanisms: FGFR inhibitor ActivBio 5mg 194 Publication
A-1114PF-04217903 Mechanisms: c-MET inhbitorActivBio5mg217 A-1114 PF-04217903 Mechanisms: c-MET inhbitor ActivBio 5mg 217
ASK
Publication
A-1205GDC-0068 Mechanisms: Akt inhibitorActivBio5mg334 A-1205 GDC-0068 Mechanisms: Akt inhibitor ActivBio 5mg 334
ASK
Publication
A-1061YM-155 Mechanisms: Survivin inhibitorActivBio5mg170 A-1061 YM-155 Mechanisms: Survivin inhibitor ActivBio 5mg 170
ASK
Publication
A-1107MK-8033 Mechanisms: c-MET inhbitorActivBio5mg545 A-1107 MK-8033 Mechanisms: c-MET inhbitor ActivBio 5mg 545 Publication
A-1002ABT-737 Mechanisms: Bcl-2 family inhibitorActivBio5mg194 A-1002 ABT-737 Mechanisms: Bcl-2 family inhibitor ActivBio 5mg 194 Publication
A-1052XL-147 Mechanisms: PI3K inhibitorActivBio5mg240 A-1052 XL-147 Mechanisms: PI3K inhibitor ActivBio 5mg 240
ASK
Publication
188-01473RANK Ligand Soluble, Human, recombinant  (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related acB-Bridge1 mg0 188-01473 RANK Ligand Soluble, Human, recombinant  (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related ac B-Bridge 1 mg 0
ASK
Publication
SO482Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 coresUS Biomax189 SO482 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189
ASK
Publication
SO8012Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 coresUS Biomax278 SO8012 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases 80 cores US Biomax 278
ASK
Publication
SO801Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases 80 coresUS Biomax231 SO801 Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases 80 cores US Biomax 231
ASK
Publication
BC24011Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 coresUS Biomax231 BC24011 Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231
ASK
Publication
BR721Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAsUS Biomax231 BR721 Breast cancer tissue array with self matching adjacent tissue and normal tissue, 24 cases 72 cores, no overlaps with other BR TMAs US Biomax 231
ASK
Publication
T242Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 coresUS Biomax88 T242 Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88
ASK
Publication
T203Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 coresUS Biomax88 T203 Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
A-1130PLX-4032 Mechanisms: B-Raf inhibitorsActivBio10mg170 A-1130 PLX-4032 Mechanisms: B-Raf inhibitors ActivBio 10mg 170 Publication
A-1185SB-939 Mechanisms: Histone deceatylase inhibitorActivBio5mg240 A-1185 SB-939 Mechanisms: Histone deceatylase inhibitor ActivBio 5mg 240
ASK
Publication
A-1112Regorafenib Mechanisms: VEGFR & Raf inhibitorActivBio5mg194 A-1112 Regorafenib Mechanisms: VEGFR & Raf inhibitor ActivBio 5mg 194 Publication
A-1001ABT-263 Mechanisms: Bcl-2 family inhibitorActivBio20mg334 A-1001 ABT-263 Mechanisms: Bcl-2 family inhibitor ActivBio 20mg 334 Publication
A-1198LY-2874455 Mechanisms: FGF FGFR inhibitorActivBio5mg311 A-1198 LY-2874455 Mechanisms: FGF FGFR inhibitor ActivBio 5mg 311
ASK
Publication
A-1102SGI-1776 Mechanisms: PIM inhibitorActivBio10mg334 A-1102 SGI-1776 Mechanisms: PIM inhibitor ActivBio 10mg 334
ASK
Publication
A-1183AZD-5363 Mechanisms: Akt inhibitorActivBio10mg299 A-1183 AZD-5363 Mechanisms: Akt inhibitor ActivBio 10mg 299
ASK
Publication
A-1194b-AP15 Mechanisms: Proteasome inhibitorActivBio5mg334 A-1194 b-AP15 Mechanisms: Proteasome inhibitor ActivBio 5mg 334
ASK
Publication
A-1901TL-32711 Mechanisms: SMAC mimeticActivBio5mg545 A-1901 TL-32711 Mechanisms: SMAC mimetic ActivBio 5mg 545 Publication
A-1118AV-951 (Tivozanib) Mechanisms: VEGFR inhibitorActivBio5mg194 A-1118 AV-951 (Tivozanib) Mechanisms: VEGFR inhibitor ActivBio 5mg 194
ASK
Publication
A-1171ASP-3026 Mechanisms: ALK inhibitorActivBio10mg240 A-1171 ASP-3026 Mechanisms: ALK inhibitor ActivBio 10mg 240 Publication
A-1219Dabrafenib Mesylate Mechanisms: B-Raf inhibitorsActivBio5mg194 A-1219 Dabrafenib Mesylate Mechanisms: B-Raf inhibitors ActivBio 5mg 194
ASK
Publication
A-1023INK-128 Mechanisms: mTORC1 C2 inhibitorActivBio10mg276 A-1023 INK-128 Mechanisms: mTORC1 C2 inhibitor ActivBio 10mg 276 Publication
A-1275GSK-126 Mechanisms: EZH2 Methyltransferase Inhibitor ActivBio5mg311 A-1275 GSK-126 Mechanisms: EZH2 Methyltransferase Inhibitor ActivBio 5mg 311
ASK
Publication
A-1117MK-1775 Mechanisms: Wee-1 inhibitorActivBio10mg240 A-1117 MK-1775 Mechanisms: Wee-1 inhibitor ActivBio 10mg 240 Publication
A-1126NVP-LDE-225 Mechanisms: Hedgehog inhibitorActivBio10mg217 A-1126 NVP-LDE-225 Mechanisms: Hedgehog inhibitor ActivBio 10mg 217
ASK
Publication
A-1007AZD-6244 Mechanisms: MEK inhibitorActivBio100mg182 A-1007 AZD-6244 Mechanisms: MEK inhibitor ActivBio 100mg 182 Publication
A-1098Carfilzomib (PR-171) Mechanisms: Proteasome inhibitorActivBio5mg229 A-1098 Carfilzomib (PR-171) Mechanisms: Proteasome inhibitor ActivBio 5mg 229
ASK
Publication
A-1064CI-1040 (PD184352) Mechanisms: MEK inhibitorActivBio5mg170 A-1064 CI-1040 (PD184352) Mechanisms: MEK inhibitor ActivBio 5mg 170
ASK
Publication
A-1033Pp-242 Mechanisms: mTORC1 C2 inhibitorActivBio10mg194 A-1033 Pp-242 Mechanisms: mTORC1 C2 inhibitor ActivBio 10mg 194 Publication
A-1126IPI-926 Mechanisms: Hedgehog inhibitorActivBio50mg2674 A-1126 IPI-926 Mechanisms: Hedgehog inhibitor ActivBio 50mg 2674
ASK
Publication
A-1005AS-703026 Mechanisms: MEK inhibitorActivBio10mg182 A-1005 AS-703026 Mechanisms: MEK inhibitor ActivBio 10mg 182 Publication
A-1091PF-03758309 Mechanisms: PAK4 inhibitorActivBio5mg188 A-1091 PF-03758309 Mechanisms: PAK4 inhibitor ActivBio 5mg 188
ASK
Publication
A-1131PLX-4720 Mechanisms: B-Raf inhibitorsActivBio10mg205 A-1131 PLX-4720 Mechanisms: B-Raf inhibitors ActivBio 10mg 205 Publication
A-1014Bortezomib (PS-341) Mechanisms: Proteasome inhibitorActivBio5mg194 A-1014 Bortezomib (PS-341) Mechanisms: Proteasome inhibitor ActivBio 5mg 194
ASK
Publication
A-1175BMS-911543 Mechanisms: JAK2 inhibitorActivBio5mg311 A-1175 BMS-911543 Mechanisms: JAK2 inhibitor ActivBio 5mg 311 Publication
A-1140TG-101348 Mechanisms: JAK2 inhibitorActivBio5mg217 A-1140 TG-101348 Mechanisms: JAK2 inhibitor ActivBio 5mg 217
ASK
Publication
A-1031Crizotinib (PF-02341066) Mechanisms: ALK and c-MET inhibitorActivBio5mg194 A-1031 Crizotinib (PF-02341066) Mechanisms: ALK and c-MET inhibitor ActivBio 5mg 194 Publication
A-1070BGT-226 Mechanisms: PI3K mTOR inhibitorActivBio5mg428 A-1070 BGT-226 Mechanisms: PI3K mTOR inhibitor ActivBio 5mg 428
ASK
Publication
A-1247AT-13387 Mechanisms: Hsp90 inhibitorActivBio5mg287 A-1247 AT-13387 Mechanisms: Hsp90 inhibitor ActivBio 5mg 287
ASK
Publication
A-1202SCH-900776 Mechanisms: CHK1 inhibitorActivBio5mg252 A-1202 SCH-900776 Mechanisms: CHK1 inhibitor ActivBio 5mg 252 Publication
A-1090AZD-2014 Mechanisms: mTORC1 C2 inhibitorActivBio5mg240 A-1090 AZD-2014 Mechanisms: mTORC1 C2 inhibitor ActivBio 5mg 240 Publication
CO702Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115US Biomax266 CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266
ASK
Publication
T203aLymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmedUS Biomax90 T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T243Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 coresUS Biomax88 T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
A-1174AZD-4547 Mechanisms: FGFR inhibitorActivBio50mg568 A-1174 AZD-4547 Mechanisms: FGFR inhibitor ActivBio 50mg 568
ASK
Publication
A-1069GDC-0980 Mechanisms: PI3K mTOR inhibitorActivBio5mg217 A-1069 GDC-0980 Mechanisms: PI3K mTOR inhibitor ActivBio 5mg 217
ASK
Publication
A-1246Dacomitinib (PF-00299804) Mechanisms: EGFR HER inhibitorActivBio5mg194 A-1246 Dacomitinib (PF-00299804) Mechanisms: EGFR HER inhibitor ActivBio 5mg 194
ASK
Publication
A-1009BEZ-235 Mechanisms: PI3K mTOR inhibitorActivBio50mg217 A-1009 BEZ-235 Mechanisms: PI3K mTOR inhibitor ActivBio 50mg 217
ASK
Publication
A-1068XL-765 (SAR-245409) Mechanisms: PI3K mTOR inhibitorActivBio5mg311 A-1068 XL-765 (SAR-245409) Mechanisms: PI3K mTOR inhibitor ActivBio 5mg 311
ASK
Publication
A-1128MEK-162 (ARRY-438162) Mechanisms: MEK inhibitorActivBio10mg182 A-1128 MEK-162 (ARRY-438162) Mechanisms: MEK inhibitor ActivBio 10mg 182
ASK
Publication
A-1008AZD-8055 Mechanisms: mTORC1 C2 inhibitorActivBio20mg311 A-1008 AZD-8055 Mechanisms: mTORC1 C2 inhibitor ActivBio 20mg 311 Publication
A-1057Cyclopamine Mechanisms: Hedgehog inhibitorActivBio10mg276 A-1057 Cyclopamine Mechanisms: Hedgehog inhibitor ActivBio 10mg 276
ASK
Publication
A-1135AZD-1480 Mechanisms: JAK2 inhibitorActivBio10mg194 A-1135 AZD-1480 Mechanisms: JAK2 inhibitor ActivBio 10mg 194 Publication
A-1036RDEA-119 (BAY-869766) Mechanisms: MEK inhibitorActivBio10mg276 A-1036 RDEA-119 (BAY-869766) Mechanisms: MEK inhibitor ActivBio 10mg 276 Publication
A-1162JNJ-26481585 Mechanisms: Histone deceatylase inhibitorActivBio5mg240 A-1162 JNJ-26481585 Mechanisms: Histone deceatylase inhibitor ActivBio 5mg 240 Publication
A-1017GDC-0941 Mechanisms: PI3K inhibitorActivBio10mg182 A-1017 GDC-0941 Mechanisms: PI3K inhibitor ActivBio 10mg 182
ASK
Publication
A-1071PKI-587 (PF-05212384) Mechanisms: PI3K mTOR inhibitorActivBio5mg276 A-1071 PKI-587 (PF-05212384) Mechanisms: PI3K mTOR inhibitor ActivBio 5mg 276
ASK
Publication
A-1055ZSTK-474 Mechanisms: PI3K inhibitorActivBio10mg170 A-1055 ZSTK-474 Mechanisms: PI3K inhibitor ActivBio 10mg 170
ASK
Publication
A-1232AZD-3514 Mechanisms: Androgen Receptor antagonistActivBio5mg217 A-1232 AZD-3514 Mechanisms: Androgen Receptor antagonist ActivBio 5mg 217
ASK
Publication
A-1187BI-6727 Mechanisms: Polo-like kinase (PLK) 1 inhibitorActivBio5mg217 A-1187 BI-6727 Mechanisms: Polo-like kinase (PLK) 1 inhibitor ActivBio 5mg 217 Publication
LC10012Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006US Biomax266 LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266
ASK
Publication
228-10441-3Human Liver FerritinRay Biotech10 mg2698 228-10441-3 Human Liver Ferritin Ray Biotech 10 mg 2698 Publication
Y104900Arginase (Bovine Liver)ABM Goods50 mg858.9 Y104900 Arginase (Bovine Liver) ABM Goods 50 mg 858.9
ASK
Publication
228-10441-2Human Liver FerritinRay Biotech1 mg717 228-10441-2 Human Liver Ferritin Ray Biotech 1 mg 717 Publication
Y107111Arginase (Bovine liver) HRP ABM Goods20 mg864.15 Y107111 Arginase (Bovine liver) HRP ABM Goods 20 mg 864.15
ASK
Publication
228-10441-1Human Liver FerritinRay Biotech200 264 228-10441-1 Human Liver Ferritin Ray Biotech 200 264 Publication
A-1059MS-275 (Entinostat) Mechanisms: Histone deceatylase inhibitorActivBio10mg170 A-1059 MS-275 (Entinostat) Mechanisms: Histone deceatylase inhibitor ActivBio 10mg 170
ASK
Publication
A-1030PD-0332991 (Palbociclib) Mechanisms: CDK4 CDK6 inhibitorActivBio5mg194 A-1030 PD-0332991 (Palbociclib) Mechanisms: CDK4 CDK6 inhibitor ActivBio 5mg 194
ASK
Publication
A-1025LBH-589 (Panobinostat) Mechanisms: Histone deceatylase inhibitorActivBio10mg182 A-1025 LBH-589 (Panobinostat) Mechanisms: Histone deceatylase inhibitor ActivBio 10mg 182
ASK
Publication
A-1101PF-04691502 Mechanisms: PI3K mTOR inhibitorActivBio10mg276 A-1101 PF-04691502 Mechanisms: PI3K mTOR inhibitor ActivBio 10mg 276
ASK
Publication
A-1214BYL-719 Mechanisms: PI3K-p110-alpha-specific inhibitorActivBio5mg287 A-1214 BYL-719 Mechanisms: PI3K-p110-alpha-specific inhibitor ActivBio 5mg 287 Publication
A-1134INCB-018424 (Ruxolitinib) Mechanisms: JAK1 2 inhibitorActivBio5mg182 A-1134 INCB-018424 (Ruxolitinib) Mechanisms: JAK1 2 inhibitor ActivBio 5mg 182 Publication
A-1159Tubastatin A Mechanisms: Histone deceatylase inhibitorActivBio10mg194 A-1159 Tubastatin A Mechanisms: Histone deceatylase inhibitor ActivBio 10mg 194
ASK
Publication
A-1113GDC-0449 (Vismodegib) Mechanisms: Hedgehog inhibitorActivBio10mg205 A-1113 GDC-0449 (Vismodegib) Mechanisms: Hedgehog inhibitor ActivBio 10mg 205
ASK
Publication
A-1125AZD-2281 (Olaparib) Mechanisms: PARP inhibitorActivBio10mg194 A-1125 AZD-2281 (Olaparib) Mechanisms: PARP inhibitor ActivBio 10mg 194
ASK
Publication
Y104900Arginase (Bovine Liver) AntibodyABM Goods50 mg760.2 Y104900 Arginase (Bovine Liver) Antibody ABM Goods 50 mg 760.2
ASK
Publication
7776-10Glucokinase, human liver, recombinantBiovision10 μg180 7776-10 Glucokinase, human liver, recombinant Biovision 10 μg 180 Publication
Y107111Arginase (Bovine liver) -HRP AntibodyABM Goods20 mg763.35 Y107111 Arginase (Bovine liver) -HRP Antibody ABM Goods 20 mg 763.35
ASK
Publication
Y107110Arginase (Bovine Liver) BIOTINABM Goods10 mg858.9 Y107110 Arginase (Bovine Liver) BIOTIN ABM Goods 10 mg 858.9
ASK
Publication
EIAAB27788CAR,CAR,Constitutive activator of retinoid response,Constitutive active response,Constitutive androstane receptor,Homo sapiens,Human,NR1I3,Nuclear receptor subfamily 1 group I member 3,Orphan nuclear EIAab1109 EIAAB27788 CAR,CAR,Constitutive activator of retinoid response,Constitutive active response,Constitutive androstane receptor,Homo sapiens,Human,NR1I3,Nuclear receptor subfamily 1 group I member 3,Orphan nuclear EIAab 1109
ASK
Publication
A-1122BIBW-2992 (Afatinib) Mechanisms: EGFR HER inhibitorActivBio10mg182 A-1122 BIBW-2992 (Afatinib) Mechanisms: EGFR HER inhibitor ActivBio 10mg 182 Publication
A-1230GSK-2636771 Mechanisms: PI3K-p110-beta-specific inhibitorActivBio5mg240 A-1230 GSK-2636771 Mechanisms: PI3K-p110-beta-specific inhibitor ActivBio 5mg 240 Publication
A-1138CAL-101 Mechanisms: PI3K-p110-delta-specific inhibitorActivBio10mg205 A-1138 CAL-101 Mechanisms: PI3K-p110-delta-specific inhibitor ActivBio 10mg 205 Publication
A-1041SAHA (Vorinostat) Mechanisms: Histone deceatylase inhibitorActivBio50mg194 A-1041 SAHA (Vorinostat) Mechanisms: Histone deceatylase inhibitor ActivBio 50mg 194
ASK
Publication
A-1274IPI-145 (INK-1197) Mechanisms: PI3K-p110-alpha-specific inhibitorActivBio5mg311 A-1274 IPI-145 (INK-1197) Mechanisms: PI3K-p110-alpha-specific inhibitor ActivBio 5mg 311
ASK
Publication
A-1158AP-24534 (Ponatinib) Mechanisms: FGFR VEGFR Bcr-Abl inhibitorActivBio10mg194 A-1158 AP-24534 (Ponatinib) Mechanisms: FGFR VEGFR Bcr-Abl inhibitor ActivBio 10mg 194 Publication
000769ACarnitine O palmitoyltransferase 1, liver isoformABM Goods250ul621 000769A Carnitine O palmitoyltransferase 1, liver isoform ABM Goods 250ul 621
ASK
Publication
BQ092A-EACNLIVER DISEASES TBA (Colorimetric) Control (1 mL vial)BioquantN/A 158 BQ092A-EACN LIVER DISEASES TBA (Colorimetric) Control (1 mL vial) Bioquant N/A 158 Publication
BQ092A-EACLLIVER DISEASES TBA (Colorimetric) Calibrator (2 mL vial)BioquantN/A 158 BQ092A-EACL LIVER DISEASES TBA (Colorimetric) Calibrator (2 mL vial) Bioquant N/A 158
ASK
Publication
ILVRC-SER Cancer samples: Liver Carcinoma SerumInnovative Research INCEach313 ILVRC-SER Cancer samples: Liver Carcinoma Serum Innovative Research INC Each 313
ASK
Publication
129-10412Mouse Anti-Human Liver Ag. Antibodies Ray Biotech1 mg452 129-10412 Mouse Anti-Human Liver Ag. Antibodies Ray Biotech 1 mg 452
ASK
Publication
ILVRC-N Cancer Samples: Liver Carcinoma PlasmaInnovative Research INCEach313 ILVRC-N Cancer Samples: Liver Carcinoma Plasma Innovative Research INC Each 313
ASK
Publication
Y107110Arginase (Bovine Liver) -BIOTIN AntibodyABM Goods10 mg760.2 Y107110 Arginase (Bovine Liver) -BIOTIN Antibody ABM Goods 10 mg 760.2
ASK
Publication
IQ289Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P)Imunquest0.2ml492 IQ289 Mouse AntiCytokeratin (keratin) type II, AE3 Target Antigen Cytokeratin (keratin) type II (AE3) Host Isotype Mouse IgG1 Application EM; IB; IHC (P) Imunquest 0.2ml 492
ASK
Publication
IQ288Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P)Imunquest0.2ml492 IQ288 Mouse AntiCytokeratin (keratin) type I (AE1) Target Antigen Cytokeratin (keratin) type I ( AE1) Host Isotype Mouse IgG1 Application EM; IB; IHC(P) Imunquest 0.2ml 492
ASK
Publication
MD-14-0291Goat Anti-Human Ferritin (Liver) Antibodies Ray Biotech1 mg318 MD-14-0291 Goat Anti-Human Ferritin (Liver) Antibodies Ray Biotech 1 mg 318 Publication
BQ013-EALDLIVER DISEASES 5' Nucleotidase (liquid stable) KitBioquant250 Tests / Kit375 BQ013-EALD LIVER DISEASES 5' Nucleotidase (liquid stable) Kit Bioquant 250 Tests / Kit 375 Publication
PA805Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802US Biomax266 PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266
ASK
Publication
BR2085cBreast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085aUS Biomax456 BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456
ASK
Publication
BR8015Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014US Biomax231 BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231
ASK
Publication
SO809Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 coresUS Biomax231 SO809 Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores US Biomax 231
ASK
Publication
ISASHPLG-GF-BIO Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, biotin labeledInnovative Research INC1.0mg460 ISASHPLG-GF-BIO Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, biotin labeled Innovative Research INC 1.0mg 460 Publication
ISASHPLG-GF-HRP Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, HRP labeledInnovative Research INC1.0mg460 ISASHPLG-GF-HRP Antibodies, Sheep: Sheep anti human plasminogen IgG fraction, HRP labeled Innovative Research INC 1.0mg 460 Publication
ISASHPLG-GF-FITCProteins and Antibodies Human and Animal Sheep anti human plasminogen IgG fraction, FITC labeledInnovative Research INC1mg421 ISASHPLG-GF-FITC Proteins and Antibodies Human and Animal Sheep anti human plasminogen IgG fraction, FITC labeled Innovative Research INC 1mg 421 Publication
ISASHPLG-GF Antibodies, Sheep: Sheep anti human plasminogen IgG fractionInnovative Research INC1.0mg395 ISASHPLG-GF Antibodies, Sheep: Sheep anti human plasminogen IgG fraction Innovative Research INC 1.0mg 395 Publication
BQ092A-EALDLIVER DISEASES Total Bile Acids (TBA) (Colorimetric) KitBioquant600 Tests / Kit501 BQ092A-EALD LIVER DISEASES Total Bile Acids (TBA) (Colorimetric) Kit Bioquant 600 Tests / Kit 501 Publication
cAP-0012Human Liver Sinusoidal Microvascular Endothelial CellsAngoiPro1.00 flask570 cAP-0012 Human Liver Sinusoidal Microvascular Endothelial Cells AngoiPro 1.00 flask 570 Publication
BQ014-EALDLIVER DISEASES Adenosine Deaminase (ADA) (liquid stable) KitBioquant250 Tests / Kit375 BQ014-EALD LIVER DISEASES Adenosine Deaminase (ADA) (liquid stable) Kit Bioquant 250 Tests / Kit 375 Publication
SO2084Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 coresUS Biomax456 SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
IFIB-1GramHuman Fibrinogen, Plasminogen Depleted 1 GramInnovative Research INC1 Gram404 IFIB-1Gram Human Fibrinogen, Plasminogen Depleted 1 Gram Innovative Research INC 1 Gram 404 Publication
IMPLA-SER-PG-10mlPlasminogen Depleted Mouse Serum 10mlInnovative Research INC10ml633 IMPLA-SER-PG-10ml Plasminogen Depleted Mouse Serum 10ml Innovative Research INC 10ml 633 Publication
HA241Colistin (Polymyxin E) ELISA kit Sensitivity 0.5ppb Sample chicken,liverWanger1 kit569.52 HA241 Colistin (Polymyxin E) ELISA kit Sensitivity 0.5ppb Sample chicken,liver Wanger 1 kit 569.52 Publication
BQ042A-EALDLIVER DISEASES Total Bile Acids (TBA) (Enzymatic Cycling) KitBioquant430 Tests / Kit514 BQ042A-EALD LIVER DISEASES Total Bile Acids (TBA) (Enzymatic Cycling) Kit Bioquant 430 Tests / Kit 514 Publication
CSB-EL010079MOMouse Glycogen [starch] synthase, liver(GYS2) ELISA kit SpeciesMouseCusabio96T816 CSB-EL010079MO Mouse Glycogen [starch] synthase, liver(GYS2) ELISA kit SpeciesMouse Cusabio 96T 816
ASK
Publication
cAP-0012RFPRFP Expressing Human Liver Sinusoidal Microvascular Endothelial CellsAngoiPro1.00 flask830 cAP-0012RFP RFP Expressing Human Liver Sinusoidal Microvascular Endothelial Cells AngoiPro 1.00 flask 830 Publication
cAP-0012GFPGFP Expressing Human Liver Sinusoidal Microvascular Endothelial CellsAngoiPro1.00 flask830 cAP-0012GFP GFP Expressing Human Liver Sinusoidal Microvascular Endothelial Cells AngoiPro 1.00 flask 830 Publication
E0973rELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptorEIAab96T845 E0973r ELISA Agtr2,Angiotensin II type-2 receptor,AT2,Rat,Rattus norvegicus,Type-2 angiotensin II receptor EIAab 96T 845 Publication
ES2001Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 coresUS Biomax516 ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores US Biomax 516
ASK
Publication
LC1002Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013US Biomax231 LC1002 Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013 US Biomax 231
ASK
Publication
22570Pyruvate Kinase(liver RBC) antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul329 22570 Pyruvate Kinase(liver RBC) antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329
ASK
Publication
BCN961Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963US Biomax231 BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 US Biomax 231
ASK
Publication
LV1001Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 coresUS Biomax231 LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231
ASK
Publication
22964alkaline phosphatase (liver bone kidney) antibody Source Rabbit Polyconal Ab Species human Application WB IHC SignalWay Antibody S.A.B 100ul329 22964 alkaline phosphatase (liver bone kidney) antibody Source Rabbit Polyconal Ab Species human Application WB IHC SignalWay Antibody S.A.B 100ul 329
ASK
Publication
IRbPLG-10mgRabbit Plasminogen 10mgInnovative Research INC10mg6970 IRbPLG-10mg Rabbit Plasminogen 10mg Innovative Research INC 10mg 6970 Publication
ICKPG-10mgChicken Plasminogen 10mgInnovative Research INC10mg4147 ICKPG-10mg Chicken Plasminogen 10mg Innovative Research INC 10mg 4147 Publication
mAP-0307Rat monoclonal anti mouse Plasminogen Kringle 5 Anti-Mouse antibodiesAngoiPro100.00 ug310 mAP-0307 Rat monoclonal anti mouse Plasminogen Kringle 5 Anti-Mouse antibodies AngoiPro 100.00 ug 310 Publication
PR-745LXR-beta Liver-X Receptor, beta-isoformhuman, recombinant, E. coliJena Bioscience10365 PR-745 LXR-beta Liver-X Receptor, beta-isoformhuman, recombinant, E. coli Jena Bioscience 10 365 Publication
BQ042A-EALD ENZYMATIC ASSAY KITS (CHEMISTRY AUTOANALYZER), LIVER DISEASES: Total Bile Acids (TBA) (Enzymatic Cycling) KitBioquant430 tests483 BQ042A-EALD ENZYMATIC ASSAY KITS (CHEMISTRY AUTOANALYZER), LIVER DISEASES: Total Bile Acids (TBA) (Enzymatic Cycling) Kit Bioquant 430 tests 483 Publication
CO243Colon cancer tissue array with normal tissue controls, 9 cases 24 coresUS Biomax88 CO243 Colon cancer tissue array with normal tissue controls, 9 cases 24 cores US Biomax 88
ASK
Publication
BN06012Normal rectum tissue (multi sites) tissue array, 70 cases 72 coresUS Biomax160 BN06012 Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores US Biomax 160
ASK
Publication
T323Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 coresUS Biomax88 T323 Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88
ASK
Publication
BN06011Normal rectum tissue (multi sites) tissue array, 23 cases 63 coresUS Biomax160 BN06011 Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores US Biomax 160
ASK
Publication
RE481Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases 48 coresUS Biomax160 RE481 Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases 48 cores US Biomax 160
ASK
Publication
RE802Rectal normal adjacent tissue and cancer tissue array, 74 cases 80 coresUS Biomax231 RE802 Rectal normal adjacent tissue and cancer tissue array, 74 cases 80 cores US Biomax 231
ASK
Publication
LY2081Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 coresUS Biomax456 LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores US Biomax 456
ASK
Publication
CR1001Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 coresUS Biomax231 CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores US Biomax 231
ASK
Publication
LC481Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 coresUS Biomax160 LC481 Tissue array of lung carcinoma and matched adjacent tissue, 12 cases 48 cores US Biomax 160
ASK
Publication
BC00116Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 coresUS Biomax231 BC00116 Carcinoma with adjacent tissue combined panel tissue array, 44 cases 48 cores US Biomax 231
ASK
Publication
FDA992FDA normal organ tissue array of human tissue, 67cases 100 coresUS Biomax278 FDA992 FDA normal organ tissue array of human tissue, 67cases 100 cores US Biomax 278
ASK
Publication
LC1007Lung tuberculosis tissue array with normal tissue, 48 cases 100 coresUS Biomax231 LC1007 Lung tuberculosis tissue array with normal tissue, 48 cases 100 cores US Biomax 231
ASK
Publication
SFD241Human soft tissue disease tissue array, 24 cases 24 coresUS Biomax166 SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
GL482Brain tumor tissue array, with normal tissue, 48 cases 48 coresUS Biomax231 GL482 Brain tumor tissue array, with normal tissue, 48 cases 48 cores US Biomax 231
ASK
Publication
OS803Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011US Biomax266 OS803 Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011 US Biomax 266
ASK
Publication
RE801Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases 80 coresUS Biomax231 RE801 Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231
ASK
Publication
ST801Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 coresUS Biomax231 ST801 Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231
ASK
Publication
SK208Skin cancer and normal tissue high density (69 cases 208 core) tissue microarrayUS Biomax456 SK208 Skin cancer and normal tissue high density (69 cases 208 core) tissue microarray US Biomax 456
ASK
Publication
BC15012Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 coresUS Biomax231 BC15012 Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 231
ASK
Publication
GL242Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 coresUS Biomax189 GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
BC02013Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 coresUS Biomax160 BC02013 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160
ASK
Publication
LC801Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 coresUS Biomax189 LC801 Lung carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores US Biomax 189
ASK
Publication
ST208Stomach cancer and normal tissue high density (70 cases 208 core) tissue microarrayUS Biomax456 ST208 Stomach cancer and normal tissue high density (70 cases 208 core) tissue microarray US Biomax 456
ASK
Publication
BC04012Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 coresUS Biomax160 BC04012 Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores US Biomax 160
ASK
Publication
HN801Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 coresUS Biomax266 HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores US Biomax 266
ASK
Publication
BC19013Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 coresUS Biomax231 BC19013 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores US Biomax 231
ASK
Publication
BC05012Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores.US Biomax231 BC05012 Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores. US Biomax 231
ASK
Publication
CO482Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 coresUS Biomax160 CO482 Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases 48 cores US Biomax 160
ASK
Publication
BC07014Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 coresUS Biomax160 BC07014 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160
ASK
Publication
BC02012Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 coresUS Biomax160 BC02012 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160
ASK
Publication
BC09012Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 coresUS Biomax231 BC09012 Endometrial carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231
ASK
Publication
BC11012Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 coresUS Biomax160 BC11012 Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores US Biomax 160
ASK
Publication
BC04021Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 coresUS Biomax160 BC04021 Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160
ASK
Publication
KD801Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases 80 coresUS Biomax231 KD801 Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases 80 cores US Biomax 231
ASK
Publication
BR8011Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 coresUS Biomax314 BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases 80 cores US Biomax 314
ASK
Publication
BC06011Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 coresUS Biomax160 BC06011 Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores US Biomax 160
ASK
Publication
FMC402Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 coresUS Biomax91 FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores US Biomax 91
ASK
Publication
MNO381Tissue profiling tissue array with 19 types of normal human tissues, 19 cases 38 coresUS Biomax166 MNO381 Tissue profiling tissue array with 19 types of normal human tissues, 19 cases 38 cores US Biomax 166
ASK
Publication
GL808Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 coresUS Biomax266 GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores US Biomax 266
ASK
Publication
MC962Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 coresUS Biomax0 MC962 Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores US Biomax 0
ASK
Publication
ST991Stomach adenocarcinoma (combination of margin and normal tissue) tissue array, 33 cases 99 coresUS Biomax231 ST991 Stomach adenocarcinoma (combination of margin and normal tissue) tissue array, 33 cases 99 cores US Biomax 231
ASK
Publication
OS804Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011US Biomax266 OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 US Biomax 266
ASK
Publication
ST802Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 coresUS Biomax231 ST802 Stomach carcinoma (multi tissue combined panel) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
KD208High density tissue array (70 cases 208 cores) of kidney cancer and normal tissueUS Biomax456 KD208 High density tissue array (70 cases 208 cores) of kidney cancer and normal tissue US Biomax 456
ASK
Publication
BC04015Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 coresUS Biomax160 BC04015 Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 160
ASK
Publication
BR1006Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 coresUS Biomax266 BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores US Biomax 266
ASK
Publication
LC803Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue arrayUS Biomax231 LC803 Lung carcinoma (multi tissue combined panel, 80 cases 80 cores) tissue array US Biomax 231
ASK
Publication
BL802Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012US Biomax266 BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266
ASK
Publication
ES8011Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 coresUS Biomax231 ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores US Biomax 231
ASK
Publication
OV807Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases 80 coresUS Biomax231 OV807 Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases 80 cores US Biomax 231
ASK
Publication
T263Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 coresUS Biomax88 T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88
ASK
Publication
LC1004Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 coresUS Biomax231 LC1004 Lung carcinoma (multi tissue combined panel) tissue array, 50 cases 100 cores US Biomax 231
ASK
Publication
TOP4-240High density tissue array of top 4 types of cancers with normal tissue control, 220 cases 240 coresUS Biomax456 TOP4-240 High density tissue array of top 4 types of cancers with normal tissue control, 220 cases 240 cores US Biomax 456
ASK
Publication
KD243Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 coresUS Biomax189 KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189
ASK
Publication
BR809Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 coresUS Biomax266 BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases 80 cores US Biomax 266
ASK
Publication
LV631Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 coresUS Biomax231 LV631 Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases 63 cores US Biomax 231
ASK
Publication
LC485Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 coresUS Biomax189 LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189
ASK
Publication
GL801Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 coresUS Biomax231 GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores US Biomax 231
ASK
Publication
OS801Osteosarcoma and chondrosarcoma tissue array, with matched or unmatched adjacent normal tissue, 79 cases 80 coresUS Biomax266 OS801 Osteosarcoma and chondrosarcoma tissue array, with matched or unmatched adjacent normal tissue, 79 cases 80 cores US Biomax 266
ASK
Publication
ES241Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 coresUS Biomax88 ES241 Esophagus cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88
ASK
Publication
LC20812Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
UT242aEndometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 24 coresUS Biomax100 UT242a Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 24 cores US Biomax 100
ASK
Publication
T204Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 coresUS Biomax88 T204 Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
SM241Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases 24 coresUS Biomax88 SM241 Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases 24 cores US Biomax 88
ASK
Publication
OV801Ovarian cancer tissue array, with matched or unmatched adjacent normal tissue, 70 cases 80 coresUS Biomax231 OV801 Ovarian cancer tissue array, with matched or unmatched adjacent normal tissue, 70 cases 80 cores US Biomax 231
ASK
Publication
TMA2081High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissueUS Biomax456 TMA2081 High density (156 cases 208 cores) tissue array of normal colon, prostate and breast tissue US Biomax 456
ASK
Publication
BRN801Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013US Biomax231 BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013 US Biomax 231
ASK
Publication
CO803Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 coresUS Biomax231 CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores US Biomax 231
ASK
Publication
BR1002Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade informationUS Biomax266 BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information US Biomax 266
ASK
Publication
LC483Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 coresUS Biomax160 LC483 Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores US Biomax 160
ASK
Publication
SK482Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 coresUS Biomax160 SK482 Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores US Biomax 160
ASK
Publication
SO241Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 coresUS Biomax88 SO241 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases 24 cores US Biomax 88
ASK
Publication
UT241Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM dataUS Biomax100 UT241 Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases 24 cores, with TNM data US Biomax 100
ASK
Publication
BO481Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM dataUS Biomax189 BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data US Biomax 189
ASK
Publication
BM482Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483US Biomax397 BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483 US Biomax 397
ASK
Publication
BN07012Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803US Biomax160 BN07012 Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803 US Biomax 160
ASK
Publication
BCN801Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 coresUS Biomax231 BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores US Biomax 231
ASK
Publication
ES208High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 coresUS Biomax456 ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores US Biomax 456
ASK
Publication
PA242Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 PA242 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
CO241Colon cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 coresUS Biomax88 CO241 Colon cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88
ASK
Publication
LP801Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 coresUS Biomax231 LP801 Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases 80 cores US Biomax 231
ASK
Publication
BN04011Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725US Biomax160 BN04011 Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725 US Biomax 160
ASK
Publication
KD485Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 coresUS Biomax189 KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases 48 cores US Biomax 189
ASK
Publication
BL242Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 coresUS Biomax189 BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189
ASK
Publication
SFT961Soft tissue tumor tissue array, 48 cases 96 coresUS Biomax225 SFT961 Soft tissue tumor tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
BC111109Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 coresUS Biomax231 BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
BC01014Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807US Biomax231 BC01014 Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 US Biomax 231
ASK
Publication
BC08015Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728US Biomax160 BC08015 Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728 US Biomax 160
ASK
Publication
RE812Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage dataUS Biomax231 RE812 Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data US Biomax 231
ASK
Publication
T291aMyeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actinUS Biomax114 T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114
ASK
Publication
SK484Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases 48 coresUS Biomax160 SK484 Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores US Biomax 160
ASK
Publication
BC01011Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721US Biomax160 BC01011 Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 US Biomax 160
ASK
Publication
CR802Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 coresUS Biomax231 CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores US Biomax 231
ASK
Publication
BC12012Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802US Biomax231 BC12012 Bladder carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BL802 US Biomax 231
ASK
Publication
KD242Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 coresUS Biomax88 KD242 Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases 24 cores US Biomax 88
ASK
Publication
PA482Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores, with TNM dataUS Biomax160 PA482 Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases 48 cores, with TNM data US Biomax 160
ASK
Publication
CR241Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 coresUS Biomax88 CR241 Cervix cancer test tissue array with self matching or unmatched normal adjacent tissue, 11 cases 24 cores US Biomax 88
ASK
Publication
T291Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases 24 coresUS Biomax100 T291 Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases 24 cores US Biomax 100
ASK
Publication
OV20810Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
T433Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases 24 coresUS Biomax88 T433 Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
BC08013Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014US Biomax160 BC08013 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014 US Biomax 160
ASK
Publication
SO481Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM informationUS Biomax160 SO481 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with TNM information US Biomax 160
ASK
Publication
CO242Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores.US Biomax88 CO242 Multiple colon cancer test tissue array with self matching normal adjacent tissue, 10 cases 24 cores. US Biomax 88
ASK
Publication
BC19012Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808US Biomax231 BC19012 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 US Biomax 231
ASK
Publication
KD482Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 coresUS Biomax160 KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores US Biomax 160
ASK
Publication
BC07013Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011US Biomax160 BC07013 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 US Biomax 160
ASK
Publication
RE482Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 coresUS Biomax160 RE482 Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores US Biomax 160
ASK
Publication
KD20810Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR803Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 US Biomax189 BR803 Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 US Biomax 189
ASK
Publication
HN241Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 HN241 Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
CR2088Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BC07012Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015US Biomax160 BC07012 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 US Biomax 160
ASK
Publication
BC11011Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 coresUS Biomax160 BC11011 Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores US Biomax 160
ASK
Publication
CO802Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801US Biomax189 CO802 Colon carcinoma (multi tissue combined panel) tissue array, 80 cases 80 cores, no overlaps with CO801 US Biomax 189
ASK
Publication
BC111110Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 coresUS Biomax231 BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231
ASK
Publication
CR2087Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 coresUS Biomax456 CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BC08016Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803US Biomax160 BC08016 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803 US Biomax 160
ASK
Publication
PR242Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 PR242 Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
TP484Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases 48 coresUS Biomax160 TP484 Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases 48 cores US Biomax 160
ASK
Publication
BC07011Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013US Biomax160 BC07011 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 US Biomax 160
ASK
Publication
BC081116Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 coresUS Biomax278 BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278
ASK
Publication
ST807Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 coresUS Biomax231 ST807 Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores US Biomax 231
ASK
Publication
BCN721Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 coresUS Biomax231 BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores US Biomax 231
ASK
Publication
CR483Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM dataUS Biomax160 CR483 Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with TNM data US Biomax 160
ASK
Publication
ES1201Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202US Biomax278 ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202 US Biomax 278
ASK
Publication
T0013Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
PR241Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243US Biomax88 PR241 Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243 US Biomax 88
ASK
Publication
T262Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 coresUS Biomax88 T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases 24 cores US Biomax 88
ASK
Publication
ES242Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases 24 coresUS Biomax88 ES242 Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases 24 cores US Biomax 88
ASK
Publication
BR20836Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
LC243Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
T009Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T009 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
OV8010Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 coresUS Biomax266 OV8010 Mid advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
PA241Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241bUS Biomax100 PA241 Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b US Biomax 100
ASK
Publication
OV243Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 OV243 Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
T0012Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
BL805Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 coresUS Biomax266 BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
HN242Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 coresUS Biomax88 HN242 Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
BR20835Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
T383Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T383 Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
STC1021Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 coresUS Biomax225 STC1021 Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores US Biomax 225
ASK
Publication
T072Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 coresUS Biomax88 T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88
ASK
Publication
T213Skin cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T213 Skin cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T008Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
BR2083High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 coresUS Biomax456 BR2083 High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456
ASK
Publication
T0011Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
TH801Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases 80 cores, no overlaps with TH802US Biomax231 TH801 Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases 80 cores, no overlaps with TH802 US Biomax 231
ASK
Publication
BR20834Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
PA243Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 PA243 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
UT242Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 UT242 Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
CO2083High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 coresUS Biomax456 CO2083 High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456
ASK
Publication
T007Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
OV208Ovarian cancer and normal tissue high density (69 cases 208 cores) tissue microarray, with grade and stage dataUS Biomax456 OV208 Ovarian cancer and normal tissue high density (69 cases 208 cores) tissue microarray, with grade and stage data US Biomax 456
ASK
Publication
T423Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T423 Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
SF961Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmedUS Biomax228 SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T0010Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
T103Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 coresUS Biomax88 T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
BR20833Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 coresUS Biomax456 BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
MC6162High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 coresUS Biomax753 MC6162 High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores US Biomax 753
ASK
Publication
PA1002Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 coresUS Biomax266 PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores US Biomax 266
ASK
Publication
CO244Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 coresUS Biomax189 CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
BL208Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage dataUS Biomax456 BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data US Biomax 456
ASK